Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
Kirby
Roger S
RS
The Prostate Centre, London, UK. bjui@theprostatecentre.com
Fitzpatrick
John M
JM
D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic / Q000592:standards*; D011471:Prostatic Neoplasms / Q000628:therapy*; D012307:Risk Factors